Summit Therapeutics Inc.
SMMT
$16.18
$0.060.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.44% | 59.03% | -799.19% | -2.79% | -8.80% |
| Total Depreciation and Amortization | 0.00% | 13.51% | 48.00% | 13.64% | 10.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.78% | -72.61% | 5,939.99% | -40.08% | -22.24% |
| Change in Net Operating Assets | 6.04% | -63.27% | 446.02% | -801.75% | -107.65% |
| Cash from Operations | -9.52% | -39.46% | -9.12% | -25.67% | -60.65% |
| Capital Expenditure | -130.99% | -- | 100.00% | -2,914.29% | 75.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -6.06% | 92.26% | 176.91% |
| Cash from Investing | -683,219.72% | -100.05% | -5.81% | 91.79% | 176.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 67.55% |
| Issuance of Common Stock | 1,597.04% | 1,421.74% | -71.06% | 764.53% | -99.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,597.04% | 1,421.74% | -71.06% | 132.51% | -111.57% |
| Foreign Exchange rate Adjustments | -186.36% | -63.93% | 60.53% | 135.19% | -194.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.59% | -168.69% | -19.04% | 861.83% | -83.03% |